BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21969603)

  • 21. Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus.
    Jia L; Coetzee GA
    Cancer Res; 2005 Sep; 65(17):8003-8. PubMed ID: 16140973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
    Yoon HG; Wong J
    Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
    Axlund SD; Lambert JR; Nordeen SK
    Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes.
    Cherian MT; Wilson EM; Shapiro DJ
    J Biol Chem; 2012 Jul; 287(28):23368-80. PubMed ID: 22589544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.
    Shi XB; Xue L; Zou JX; Gandour-Edwards R; Chen H; deVere White RW
    Prostate; 2008 Dec; 68(16):1816-26. PubMed ID: 18780293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA.
    Wang D; Garcia-Bassets I; Benner C; Li W; Su X; Zhou Y; Qiu J; Liu W; Kaikkonen MU; Ohgi KA; Glass CK; Rosenfeld MG; Fu XD
    Nature; 2011 May; 474(7351):390-4. PubMed ID: 21572438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks.
    Barfeld SJ; Urbanucci A; Itkonen HM; Fazli L; Hicks JL; Thiede B; Rennie PS; Yegnasubramanian S; DeMarzo AM; Mills IG
    EBioMedicine; 2017 Apr; 18():83-93. PubMed ID: 28412251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers.
    Makkonen H; Kauhanen M; Paakinaho V; Jääskeläinen T; Palvimo JJ
    Nucleic Acids Res; 2009 Jul; 37(12):4135-48. PubMed ID: 19433513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic methylation of histone H3 at lysine 4 in transcriptional regulation by the androgen receptor.
    Kim J; Jia L; Tilley WD; Coetzee GA
    Nucleic Acids Res; 2003 Dec; 31(23):6741-7. PubMed ID: 14627807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KAT8 Regulates Androgen Signaling in Prostate Cancer Cells.
    Kim JY; Yu J; Abdulkadir SA; Chakravarti D
    Mol Endocrinol; 2016 Aug; 30(8):925-36. PubMed ID: 27268279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
    Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
    Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The p14ARF tumor suppressor restrains androgen receptor activity and prevents apoptosis in prostate cancer cells.
    Siddiqui S; Libertini SJ; Lucas CA; Lombard AP; Baek HB; Nakagawa RM; Nishida KS; Steele TM; Melgoza FU; Borowsky AD; Durbin-Johnson BP; Qi L; Ghosh PM; Mudryj M
    Cancer Lett; 2020 Jul; 483():12-21. PubMed ID: 32330514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens.
    Dart DA; Brooke GN; Sita-Lumsden A; Waxman J; Bevan CL
    Oncogene; 2012 Oct; 31(43):4588-98. PubMed ID: 22179832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probasin promoter assembles into a strongly positioned nucleosome that permits androgen receptor binding.
    Maffey AH; Ishibashi T; He C; Wang X; White AR; Hendy SC; Nelson CC; Rennie PS; Ausió J
    Mol Cell Endocrinol; 2007 Mar; 268(1-2):10-9. PubMed ID: 17316977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.
    Cleutjens KB; van der Korput HA; van Eekelen CC; van Rooij HC; Faber PW; Trapman J
    Mol Endocrinol; 1997 Feb; 11(2):148-61. PubMed ID: 9013762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential requirement of SWI/SNF for androgen receptor activity.
    Marshall TW; Link KA; Petre-Draviam CE; Knudsen KE
    J Biol Chem; 2003 Aug; 278(33):30605-13. PubMed ID: 12775722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of histone deacetylation augments dihydrotestosterone induction of androgen receptor levels: an explanation for trichostatin A effects on androgen-induced chromatin remodeling and transcription of the mouse mammary tumor virus promoter.
    List HJ; Smith CL; Rodriguez O; Danielsen M; Riegel AT
    Exp Cell Res; 1999 Nov; 252(2):471-8. PubMed ID: 10527637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OCT4 establishes and maintains nucleosome-depleted regions that provide additional layers of epigenetic regulation of its target genes.
    You JS; Kelly TK; De Carvalho DD; Taberlay PC; Liang G; Jones PA
    Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14497-502. PubMed ID: 21844352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic nucleosome landscape elicits a noncanonical GATA2 pioneer model.
    Li T; Liu Q; Chen Z; Fang K; Huang F; Fu X; Wang Q; Jin VX
    Nat Commun; 2022 Jun; 13(1):3145. PubMed ID: 35672415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
    Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.